Literature DB >> 33061000

"RFEF" and mitral regurgitation jet direction: surrogate markers for likelihood of left ventricle reverse remodeling in patients with moderate chronic ischemic mitral regurgitation.

Sumbul Siddiqui1, Amber Malhotra1, Komal Shah2, Pankaj Garg1, Pranav Sharma1, Vivek Wadhawa1, Kartik Patel1, Anand Shukla3.   

Abstract

PURPOSE: Surgical management of moderate chronic ischemic mitral regurgitation (CIMR) is controversial. We propose a simplified classification of moderate CIMR based on regurgitant fraction (RF), ejection fraction (EF), and jet direction (central/eccentric) to predict left ventricle (LV) remodeling and identify patient subsets which need mitral valve (MV) repair along with coronary artery bypass grafting (CABG).
METHODS: In this prospective controlled study (n = 210), patients with moderate CIMR were randomized. Group I (n = 106) underwent off-pump CABG alone while group II (n = 104) underwent CABG + MV repair. The product of regurgitation fraction and ejection fraction ("RFEF") was taken as a surrogate for myocardial reserve. The cut-off defined was 0.12; patients with RFEF ≤ 0.12 were categorized as the "bad" and those with RFEF > 0.12 as the "good" subset. The patients were further subdivided on the basis of their mitral regurgitation (MR) jet direction (central/eccentric). The percentage improvement in left ventricular end-systolic volume index (LVESVI) and MR grade were recorded 6 monthly.
RESULTS: Analysis of the continuous variable "RFEF" in conjunction with jet direction was performed. At 12 months, the patient in good subset with central direction of jet showed improvement in LVESVI % in both groups (p = 0.428), while the patients in bad subset with eccentric direction of jet showed significantly higher improvement in LVESVI %, group II as compared to group I (p = 0.004).
CONCLUSION: This study thus identifies "RFEF" as a surrogate for reverse remodeling capacity. In association with MR jet direction, predicts the subset of moderate CIMR patients most likely to have maximum LVESVI and MR grade reduction. © Indian Association of Cardiovascular-Thoracic Surgeons 2018.

Entities:  

Keywords:  Coronary artery disease; Heart failure; Ischemic mitral regurgitation

Year:  2018        PMID: 33061000      PMCID: PMC7525430          DOI: 10.1007/s12055-018-0717-0

Source DB:  PubMed          Journal:  Indian J Thorac Cardiovasc Surg        ISSN: 0970-9134


  35 in total

1.  The importance of grade 2 ischemic mitral regurgitation in coronary artery bypass grafting.

Authors:  T Rydén; O Bech-Hanssen; G Brandrup-Wognsen; F Nilsson; S Svensson; A Jeppsson
Journal:  Eur J Cardiothorac Surg       Date:  2001-08       Impact factor: 4.191

2.  Value of the regurgitant volume to end diastolic volume ratio to predict the regression of left ventricular dimensions after valve replacement in aortic insufficiency.

Authors:  P Fioretti; J Roelandt; C Tirtaman; E Bos; P W Serruys
Journal:  Eur Heart J       Date:  1987-08       Impact factor: 29.983

3.  Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment.

Authors:  F Grigioni; M Enriquez-Sarano; K J Zehr; K R Bailey; A J Tajik
Journal:  Circulation       Date:  2001-04-03       Impact factor: 29.690

4.  Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation.

Authors:  Sandro Gelsomino; Roberto Lorusso; Irene Capecchi; Carlo Rostagno; Stefano Romagnoli; Giuseppe Billè; Giuseppe De Cicco; Cecilia Tetta; Pierluigi Stefàno; Gian Franco Gensini
Journal:  Ann Thorac Surg       Date:  2008-04       Impact factor: 4.330

5.  Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting.

Authors:  Sandro Gelsomino; Roberto Lorusso; Sabina Caciolli; Irene Capecchi; Carlo Rostagno; Marco Chioccioli; Giuseppe De Cicco; Giuseppe Billè; Pierluigi Stefàno; Gian Franco Gensini
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-02       Impact factor: 5.209

6.  Functional mitral regurgitation in chronic ischemic coronary artery disease: analysis of geometric alterations of mitral apparatus with magnetic resonance imaging.

Authors:  Hsi-Yu Yu; Mao-Yuan Su; Ta-Yu Liao; Hsu-Hsia Peng; Fang-Yue Lin; Wen-Yih Isaac Tseng
Journal:  J Thorac Cardiovasc Surg       Date:  2004-10       Impact factor: 5.209

7.  Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling.

Authors:  Jeroen J Bax; Jerry Braun; Soeresh T Somer; Robert Klautz; Eduard R Holman; Michel I M Versteegh; Eric Boersma; Martin J Schalij; Ernst E van der Wall; Robert A Dion
Journal:  Circulation       Date:  2004-09-14       Impact factor: 29.690

Review 8.  Ischemic mitral regurgitation: a complex multifaceted disease.

Authors:  Julien Magne; Mario Sénéchal; Jean G Dumesnil; Philippe Pibarot
Journal:  Cardiology       Date:  2008-08-30       Impact factor: 1.869

9.  Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.

Authors:  Robert E Michler; Peter K Smith; Michael K Parides; Gorav Ailawadi; Vinod Thourani; Alan J Moskowitz; Michael A Acker; Judy W Hung; Helena L Chang; Louis P Perrault; A Marc Gillinov; Michael Argenziano; Emilia Bagiella; Jessica R Overbey; Ellen G Moquete; Lopa N Gupta; Marissa A Miller; Wendy C Taddei-Peters; Neal Jeffries; Richard D Weisel; Eric A Rose; James S Gammie; Joseph J DeRose; John D Puskas; François Dagenais; Sandra G Burks; Ismail El-Hamamsy; Carmelo A Milano; Pavan Atluri; Pierre Voisine; Patrick T O'Gara; Annetine C Gelijns
Journal:  N Engl J Med       Date:  2016-04-03       Impact factor: 91.245

10.  Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial.

Authors:  K M John Chan; Prakash P Punjabi; Marcus Flather; Riccardo Wage; Karen Symmonds; Isabelle Roussin; Shelley Rahman-Haley; Dudley J Pennell; Philip J Kilner; Gilles D Dreyfus; John R Pepper
Journal:  Circulation       Date:  2012-11-07       Impact factor: 29.690

View more
  1 in total

1.  Isolated OPCABG in moderate chronic ischemic mitral regurgitation: is it a justifiable alternative approach ?

Authors:  Amber Malhotra; Pankaj Garg; Sumbul Siddiqui; Komal Shah
Journal:  Gen Thorac Cardiovasc Surg       Date:  2022-05-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.